Related references
Note: Only part of the references are listed.Solubility measurement and correlation for HNIW•TNT co-crystal in nine pure solvents from T = (283.15 to 318.15) K
Qian Jia et al.
JOURNAL OF MOLECULAR LIQUIDS (2021)
Thermodynamic analysis of the solubility of clozapine in organic solvents
Shuai Yu et al.
JOURNAL OF CHEMICAL THERMODYNAMICS (2021)
Comments on Measurement and correlation of the solubility of estradiol and estradiol-urea co-crystal in fourteen pure solvents at temperatures from 273.15 K to 318.15 K
Ali Shayanfar
JOURNAL OF MOLECULAR LIQUIDS (2020)
Measurement and Modeling of Solubility of Galactose in Aqueous Ionic Liquids, 1-Butyl-3-Methyl Imidazolium Bromide, 1-Hexyl-3-Methyl Imidazolium Bromide and 1-Butyl-3-Methylimidazolium Chloride at T = (298.15 And 308.15) K
Mohammed Taghi Zafarani-Moattar et al.
PHARMACEUTICAL SCIENCES (2019)
Understanding the Differences Between Cocrystal and Salt Aqueous Solubilities
Katie L. Cavanagh et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Cocrystal solubility product analysis - Dual concentration-pH mass action model not dependent on explicit solubility equations
Alex Avdeef
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Cocrystals to facilitate delivery of poorly soluble compounds beyond-rule-of-5
Gislaine Kuminek et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Thermodynamic Solubility Profile of Carbamazepine-Cinnamic Acid Cocrystal at Different pH
Fatemeh Keramatnia et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Solubility of carbamazepine, nicotinamide and carbamazepine-nicotinamide cocrystal in ethanol-water mixtures
Ali Shayanfar et al.
FLUID PHASE EQUILIBRIA (2014)
Pharmaceutical cocrystals and poorly soluble drugs
Ranjit Thakuria et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Solubility Advantage of Pharmaceutical Cocrystals
David J. Good et al.
CRYSTAL GROWTH & DESIGN (2009)
Share Paper
